Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T09:10:29.873Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased pulmonary blood flow

Published online by Cambridge University Press:  21 July 2011

İlknur Tolunay ,
Sedef Tunaoglu ,
Nalan Akyürek ,
Velit Halid ,
Rana Olgunturk  and
Serdar Kula
İlknur Tolunay
Affiliation:
Department of Pediatrics, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
Sedef Tunaoglu*
Affiliation:
Department of Pediatric Cardiology, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
Nalan Akyürek
Affiliation:
Department of Pathology, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
Velit Halid
Affiliation:
Department of Cardiovascular Surgery, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
Rana Olgunturk
Affiliation:
Department of Pediatric Cardiology, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
Serdar Kula
Affiliation:
Department of Pediatric Cardiology, Medical Faculty, Gazi University, Gazi Hospital, Besevler, Ankara, Turkey
*
Correspondence to: Professor Dr S. Tunaoglu, Department of Pediatric Cardiology, Gazi University, Medical Faculty, Gazi Hospital, Besevler, Ankara, Turkey. Tel: 00903122025626; Fax: 00903122130145; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Tetralogy of Fallot is the most common cyanotic congenital heart disease with decreased pulmonary blood flow. Right-to-left shunt and infundibular pulmonary stenosis in this disease lead to a decrease in arterial O2 saturation. Hypoxia is a strong stimulus for angiogenesis; however, the reason for insufficiency in the pulmonary vascular growth in patients despite chronic arterial hypoxia is still not known. This study was planned considering that the impairment in vascular endothelial growth factor-receptor relationship or the vascular endothelial growth factor-receptor deficiency in the pulmonary vascular bed during development may cause insufficiency of pulmonary vascular growth. A total of 24 patients were grouped as cyanotic – including 13 patients with tetralogy of Fallot – and acyanotic – including 11 patients with left-to-right shunt lesions. During cardiac catheterisation, vascular endothelial growth factor measurements were performed; and oxygen saturations, pressures, and haemoglobin levels were measured. Perioperative lung biopsy for vascular endothelial growth factor receptors was performed in the cyanotic group. Vascular endothelial growth factor of the aorta was higher in the acyanotic group. There was a significant negative correlation between vascular endothelial growth factor levels and aortic O2 saturation in the cyanotic group (p < 0.05). Vascular endothelial growth factor tissue staining was negative in 11 out of 13 (84.6%) patients. KDR/Flk-1 receptor was positive in four out of 13 (30.7%) patients; Flt-1 receptor was positive in six out of 13 (46.1%) patients. Vascular endothelial growth factor values were found to be lower than those of the acyanotic patients in this study. Low serum vascular endothelial growth factor levels of the cyanotic group, in spite of the hypoxia, demonstrated the importance of studying vascular endothelial growth factor tissue levels and vascular endothelial growth factor receptors in these patients.

Keywords

KDR/Flk-1Flt-1shunt lesions
Type
Original Articles
Information
Cardiology in the Young , Volume 21 , Issue 6 , 28 October 2011 , pp. 608 - 615
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Brogi, E, Wu, T, Namiki, A, Isner, JM. Indirect angiogenic cytokines upregulate vascular endothelial growth factor and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates vascular endothelial growth factor expression only. Circulation 1994; 90: 649–652.CrossRefGoogle Scholar
2.Hanahan, D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48–50.CrossRefGoogle ScholarPubMed
3.Minchenko, A, Bauer, T, Salceda, S, Caro, J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994; 71: 374–379.Google ScholarPubMed
4.Neufeld, G, Cohen, T, Gengrinovitch, S, Poltorak, Z. Vascular endothelial growth factor (vascular endothelial growth factor) and its receptors. FASEB J 1999; 13: 9–22.CrossRefGoogle ScholarPubMed
5.Hamada, H, Ebata, R, Higashi, K, et al. Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro. Int J Cardiol 2007; 120: 66–71.CrossRefGoogle ScholarPubMed
6.Himeno, W, Akagi, T, Furui, J, et al. Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol 2003; 24: 127–132.CrossRefGoogle ScholarPubMed
7.Ootaki, Y, Yamaguchi, M, Yoshimura, N, Oka, S, Yoshida, M, Hasegawa, T. Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg 2003; 75: 1523–1526.CrossRefGoogle ScholarPubMed
8.Starnes, SL, Duncan, BW, Kneebone, JM, et al. Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease. J Thorac Cardiovasc Surg 2000; 119: 534–539.CrossRefGoogle ScholarPubMed
9.Tunaoğlu, FS, Kula, S, Zengin, A, Olguntürk, R, Saygılı, A, Oğuz, D. Vascular endothelial growth factor, IL-6 and IL-8 levels in congenital heart disease. 42nd Annual Meeting of the Association for European Pediatric Cardiology, 16–19 May 2007, Warsaw, Poland. Cardiol Young 2007; 17 Suppl 1: 56.Google Scholar
10.Sewik, ES, Erenberg, F, Zahka, KG, Goldmuntz, E. Tetralogy of Fallot. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds). Moss and Adams’ Heart Disease in Infants, Children, and Adolescents, 7th edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2008, pp. 888–910.Google Scholar
11.Geiger, R, Berger, RM, Hess, J, Bogers, AJ, Sharma, HS, Mooi, WJ. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 2000; 191: 202–207.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
12.Baumgartner, I, Pieczek, A, Manor, O, et al. Constitutive expression of phvascular endothelial growth factor165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114–1123.CrossRefGoogle Scholar